PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
18.28%
Revenue growth at 50-75% of 6203.T's 29.49%. Martin Whitman would worry about competitiveness or product relevance.
14.06%
Gross profit growth above 1.5x 6203.T's 5.08%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
2.39%
EBIT growth 1.25-1.5x 6203.T's 1.97%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
41.30%
Operating income growth above 1.5x 6203.T's 1.97%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
-38.44%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-38.37%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-38.09%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.03%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.03%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.73%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-21.98%
Negative 5Y CAGR while 6203.T stands at 31.52%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-23.01%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-78.75%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-70.48%
Negative 5Y net income/share CAGR while 6203.T is 285.88%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-81.25%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
268.61%
10Y equity/share CAGR above 1.5x 6203.T's 39.14%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
54.47%
5Y equity/share CAGR above 1.5x 6203.T's 14.41%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
21.53%
3Y equity/share CAGR above 1.5x 6203.T's 12.76%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
15.66%
AR growth well above 6203.T's 16.80%. Michael Burry fears inflated revenue or higher default risk in the near future.
-22.64%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
3.44%
Asset growth 1.25-1.5x 6203.T's 2.69%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
3.60%
1.25-1.5x 6203.T's 3.19%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-33.71%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
18.29%
R&D dropping or stable vs. 6203.T's 520.69%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
8.68%
SG&A growth well above 6203.T's 6.16%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.